在瘤进展和转移中,YAP/TAZ信号网络的多功能调节
Hannah L Thrash1, Ann Marie Pendergast1
1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA.
Cancers
|October 14, 2023
概括
河马通路蛋白YAP和TAZ通过调节基因表达来驱动瘤生长,转移和治疗抵抗. 针对这些联合激活剂为治疗固体瘤提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 河马通路的协同激活剂,YES相关蛋白 (YAP) 和具有PDZ结合因子 (TAZ) 的转录协同激活剂,都与瘤进展和转移有关.
- YAP/TAZ蛋白调节参与细胞增殖,生存,迁移和入侵的基因,这是癌症发展的关键过程.
研究的目的:
- 审查YAP/TAZ信号传递在瘤细胞可塑性,上皮-介质细胞转换 (EMT) 和癌症干细胞表型中的作用.
- 详细介绍YAP/TAZ调解瘤生长,转移和治疗耐药性的机制.
- 讨论针对固体瘤中YAP/TAZ功能的新型治疗策略.
主要方法:
- 在癌症中对YAP/TAZ信号网络的文献综述.
- 对YAP/TAZ依赖的转录调节的分析.
- 讨论针对YAP/TAZ的治疗策略.
主要成果:
- YAP/TAZ信号涉及混合和可逆EMT状态,促进瘤细胞的可塑性.
- YAP/TAZ通路有助于癌症干细胞表型,增强瘤的进展.
- 失调的YAP/TAZ活性与各种固体瘤的治疗耐药性有关.
结论:
- 通过转录调节,YAP和TAZ在瘤生长,转移和治疗耐药性方面发挥着关键作用.
- 了解YAP/TAZ的不同和重叠的功能是开发有效癌症治疗的关键.
- 针对YAP/TAZ过激活是一种有希望的治疗途径,用于固体瘤.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.9K
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
3.0K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
